Latest filing published 09 Feb 2018 for CanniMed Therapeutics Inc., €7,856.
Bruce mackler appears in our data through filings on CanniMed Therapeutics Inc. shares, published by SEDI. We count 4 filings; the first trade dates from 1 November 2016 and the latest from 8 February 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 9 February 2018: an option exercise of €7,856, in CanniMed Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 30 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations